TREATMENT MODALITY

LACVT provides a unique and groundbreaking patented approach called Physiologic Insulin Resensitazation where insulin is administered as a hormone rather than a drug; addressing the primary cause of Diabetes which is metabolic failure. By utilizing insulin in a manner that bio-mimics normal physiology, this modality is designed to reduce insulin resistance which helps blood sugar more readily enter each cell and be converted into energy.

Increasing cellular energy allows damaged tissues and organs to grow, repair, and regenerate. Thus, our approach not only stabilizes but in many instances has reversed complications of diabetes and other metabolic disorders.

Amputees, seniors, readmitted patients, diabetics, cardiac patients, cancer survivors, surgical patients, and even veterans are at risk of complications from wounds. As such, become aware, intervene early, and seek advanced wound care at the Louisiana Cardiovascular & Thoracic Institute today.